# EDGAR Filing Document

**Accession Number:** 0000101538
**File Stem:** 0001654954-25-009449
**Filing Date:** 2025-8
**Character Count:** 125348
**Document Hash:** 5670eb1de3186de40204abc9c5b330c9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001654954-25-009449.hdr.sgml**: 20250812

**ACCESSION NUMBER**: 0001654954-25-009449

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 82

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250812

**DATE AS OF CHANGE**: 20250812

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** UNITED STATES ANTIMONY CORP
- **CENTRAL INDEX KEY:** 0000101538
- **STANDARD INDUSTRIAL CLASSIFICATION:** PRIMARY SMELTING & REFINING OF NONFERROUS METALS [3330]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 810305822
- **STATE OF INCORPORATION:** MT
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-08675
- **FILM NUMBER:** 251207753

**BUSINESS ADDRESS:**
- **STREET 1:** 4438 W LOVER'S LANE
- **STREET 2:** UNIT 100
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75209
- **BUSINESS PHONE:** 4068273523

**MAIL ADDRESS:**
- **STREET 1:** PO BOX 540308
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75354

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AGAU MINES INC
- **DATE OF NAME CHANGE:** 19740728

?xml version='1.0' encoding='ASCII'? uamy_10q.htm

 **UNITED STATES**

 **SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 10-Q**

(Mark One)

**☒** **Quarterly Report Pursuant to Section 13 Or 15(d) Of The Securities Exchange Act of 1934**

For the quarterly period ended **<u>June 30, 2025</u>**

**☐** **Transition Report Under Section 13 Or 15(d) Of The Securities Exchange Act of 1934**

For the transition period ________ to ________

**COMMISSION FILE NUMBER <u>001-08675</u>**

---

| |
|:---|
| **UNITED STATES ANTIMONY CORPORATION** |
| (Exact name of registrant as specified in its charter)  |

---

---

| | |
|:---|:---|
| **Montana**  | **81-0305822** |
| (State or other jurisdiction of<br> incorporation or organization) | (IRS Employer <br>Identification No.) |
| **4438 W. Lovers Lane, Unit 100, Dallas, TX** | **75209** |
| (Address of principal executive office) | (Postal Code) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>(406) 606-4117</u>**

(Registrant's telephone number)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of Each Class** | **Trading Symbol** | **Name of Each Exchange on Which Registered** |
| Common Stock, $0.01 par value <br>Common Stock, $0.01 par value | UAMY<br>UAMY | NYSE American<br>NYSE Texas |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. **Yes ☒ No** ☐

Indicate by checkmark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post filed). **Yes ☒** No ☐

Indicate by checkmark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of "Accelerated filer and large accelerated filer" in Rule 12b-2 of the Exchange Act (Check one):

---

| | | | |
|:---|:---|:---|:---|
| Large Accelerated Filer | ☐ | Accelerated Filer | ☐ |
| Non-accelerated Filer | ☒ | Smaller Reporting Company  | ☒ |
| Emerging Growth Company | ☐ |  |  |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ **No ☒**

As of August 8, 2025, there were 120,723,320 shares outstanding of the registrant's $0.01 par value common stock.

**Table of Contents**

---

| | | |
|:---|:---|:---|
| [PART I - FINANCIAL INFORMATION](#p1) | [PART I - FINANCIAL INFORMATION](#p1) |  |
| [ITEM 1.](#i1) | [FINANCIAL STATEMENTS](#i1) | 3 |
| [ITEM 2.](#i2) | [MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION.](#i2) | 24 |
| [ITEM 3.](#i3) | [QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK](#i3) | 32 |
| [ITEM 4.](#i4) | [CONTROLS AND PROCEDURES](#i4) | 32 |
| [PART II - OTHER INFORMATION](#p2) | [PART II - OTHER INFORMATION](#p2) |  |
| [ITEM 1.](#p2i1) | [LEGAL PROCEEDINGS.](#p2i1) | 33 |
| [ITEM 1A.](#p2ia) | [RISK FACTORS.](#p2ia) | 33 |
| [ITEM 2.](#p2i2) | [RECENT SALES OF UNREGISTERED SECURITIES.](#p2i2) | 33 |
| [ITEM 3.](#p2i3) | [DEFAULTS UPON SENIOR SECURITIES.](#p2i3) | 33 |
| [ITEM 4.](#p2i4) | [MINE SAFETY DISCOSURES.](#p2i4) | 34 |
| [ITEM 5.](#p2i5) | [OTHER INFORMATION.](#p2i5) | 34 |
| [ITEM 6.](#i6) | [EXHIBITS.](#i6) | 34 |

---

---

| |
|:---|
| 2 |
| *[**Table of Contents**](#TOC)* |

---

**PART I - FINANCIAL INFORMATION**

**ITEM 1. FINANCIAL STATEMENTS**

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)**

---

| | | |
|:---|:---|:---|
|  | **June 30,** <br>**2025** | **December 31,**<br> **2024** |
| **ASSETS** |  |  |
| CURRENT ASSETS |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $5708660 | $18172120 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment securities held to maturity | 1258665 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | 2543413 | 1156564 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 6812527 | 1245724 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 1353208 | 104161 |
| Total current assets | 17676473 | 20678569 |
| Property, plant and equipment, net  | 19725995 | 12891447 |
| Operating lease right-of-use assets | 275627 | 565289 |
| Investment securities held to maturity - noncurrent | 8828584 |  |
| Restricted cash for reclamation bonds | 99764 | 98778 |
| IVA receivable and other assets, net | 891879 | 408519 |
| Total assets | $47498322 | $34642602 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| CURRENT LIABILITIES |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $5746709 | $1545708 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | 1251778 | 1427146 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities - directors | 88750 | 141287 |
| &nbsp;&nbsp;&nbsp;&nbsp;Royalties payable | 182523 | 133434 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of operating lease liabilities | 592695 | 626562 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of long-term debt | 134577 | 132252 |
| Total current liabilities | 7997032 | 4006389 |
| Operating lease liabilities, net of current portion | 117722 | 129007 |
| Long-term debt, net of current portion  | 127550 | 195425 |
| Asset retirement obligations | 1750075 | 1711108 |
| Total liabilities | 9992379 | 6041929 |
| COMMITMENTS AND CONTINGENCIES (Note 12) |  |  |
| STOCKHOLDERS' EQUITY |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Preferred stock $0.01 par value, 10,000,000 shares authorized: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series A - no shares issued and outstanding |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series B - 750,000 shares issued and outstanding (liquidation preference $978,750 and $975,000, respectively)  | 7500 | 7500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series C - 177,904 shares issued and outstanding (liquidation preference $97,847 both periods) | 1779 | 1779 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series D - no shares issued and outstanding |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock, $0.01 par value, 250,000,000 shares authorized; 119,200,980 and 112,951,317 shares issued and outstanding, respectively | 1192010 | 1129512 |
| Additional paid-in capital | 76725598 | 68610905 |
| Accumulated deficit | (40420944) | (41149023) |
| Total stockholders' equity | 37505943 | 28600673 |
| Total liabilities and stockholders' equity  | $47498322 | $34642602 |

---

The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.

---

| |
|:---|
| 3 |
| *[**Table of Contents**](#TOC)* |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Revenues | $10525123 | $3662977 | $17525128 | $6735044 |
| Cost of revenues | 7687578 | 2412754 | 12315853 | 4895336 |
| Gross profit | 2837545 | 1250223 | 5209275 | 1839708 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 842951 | 502874 | 1393546 | 1003160 |
| &nbsp;&nbsp;&nbsp;&nbsp;Salaries and benefits | 1364506 | 285359 | 2365061 | 526964 |
| &nbsp;&nbsp;&nbsp;&nbsp;Professional fees | 536869 | 240708 | 918905 | 453016 |
| &nbsp;&nbsp;&nbsp;&nbsp;(Gain) loss on sale or disposal of property, plant and equipment, net |  |  | (500) | 17494 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other operating expenses | 73212 | 165274 | 154264 | 253520 |
| Total operating expenses | 2817538 | 1194215 | 4831276 | 2254154 |
| Income (loss) from operations | 20007 | 56008 | 377999 | (414446) |
| Other income (expense), net: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest and investment income | 154770 | 151921 | 322156 | 302772 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trademark and licensing income | 6627 | 8360 | 17470 | 14728 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other miscellaneous income (expense) | 151 | (13497) | 10454 | (23030) |
| Total other income, net | 161548 | 146784 | 350080 | 294470 |
| Income (loss) before income taxes | 181555 | 202792 | 728079 | (119976) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense | - | - | - | - |
| Net income (loss) | 181555 | 202792 | 728079 | (119976) |
| &nbsp;&nbsp;&nbsp;&nbsp;Preferred dividends | (1875) | (1875) | (3750) | (3750) |
| Net income (loss) available to common shareholders | $179680 | $200917 | $724329 | $(123726) |
| Net income (loss) per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $nil | $nil | $0.01 | $nil |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $nil | $nil | $0.01 | $nil |
| Weighted average shares outstanding: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 118261366 | 108438984 | 115994982 | 108173645 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 127223435 | 108943126 | 124343635 | 108173645 |

---

The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.

---

| |
|:---|
| 4 |
| *[**Table of Contents**](#TOC)* |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)**

**For the three and six months ended June 30, 2025 and 2024**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Preferred Stock** | **Preferred Stock** | **Common stock** | **Common stock** | | | |
|  | **Shares** | **Par Value** | **Shares** | **Par Value** | **Additional**<br>**Paid-In**<br>**Capital** | **Accumulated** <br>**Deficit** | **Total Stockholders'** <br>**Equity** |
| **Balance - December 31, 2024** | 927904 | $9279 | 112951317 | $1129512 | $68610905 | $(41149023) | $28600673 |
| Net income |  |  |  |  |  | 546524 | 546524 |
| Share-based compensation |  |  |  |  | 245384 |  | 245384 |
| Exercise of stock options and distribution of restricted stock units |  |  | 1101231 | 11013 | (11013) |  |  |
| Issuance of common stock for cash, net of issuance costs |  |  | 1107923 | 11079 | 2381238 |  | 2392317 |
| Issuance of common stock upon exercise of warrants | - | - | 948750 | 9488 | 796950 | - | 806438 |
| **Balance - March 31, 2025** | 927904 | 9279 | 116109221 | 1161092 | 72023464 | (40602499) | 32591336 |
| Net income |  |  |  |  |  | 181555 | 181555 |
| Share-based compensation |  |  |  |  | 586913 |  | 586913 |
| Exercise of stock options and distribution of restricted stock units |  |  | 370866 | 3709 | 51291 |  | 55000 |
| Issuance of common stock for cash, net of issuance costs |  |  | 750000 | 7500 | 2664666 |  | 2672166 |
| Issuance of common stock upon exercise of warrants | - | - | 1970893 | 19709 | 1399264 | - | 1418973 |
| **Balance - June 30, 2025** | 927904 | $9279 | 119200980 | $1192010 | $76725598 | $(40420944) | $37505943 |
|  | **Preferred Stock** | **Preferred Stock** | **Common stock** | **Common stock** | **Additional**<br>**Paid-In** | **Accumulated** | **Total Stockholders'** |
|  | **Shares** | **Par Value** | **Shares** | **Par Value** | **Capital** | **Deficit** | **Equity** |
| **Balance - December 31, 2023** | 927904 | $9279 | 107647317 | $1076472 | $63853836 | $(39418619) | $25520968 |
| Net loss |  |  |  |  |  | (322768) | (322768) |
| Share-based compensation |  |  |  |  | 205925 |  | 205925 |
| Distribution of restricted stock units | - | - | 791667 | 7917 | (7917) | - | - |
| **Balance - March 31, 2024** | 927904 | 9279 | 108438984 | 1084389 | 64051844 | (39741387) | 25404125 |
| Net income |  |  |  |  |  | 202792 | 202792 |
| Share-based compensation | - | - | - | - | 94922 | - | 94922 |
| **Balance - June 30, 2024** | 927904 | $9279 | 108438984 | $1084389 | $64146766 | $(39538595) | $25701839 |

---

The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.

---

| |
|:---|
| 5 |
| *[**Table of Contents**](#TOC)* |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)**

---

| | | |
|:---|:---|:---|
|  | **For the six months**<br>**ended June 30,** | **For the six months**<br>**ended June 30,** |
|  | **2025** | **2024** |
| **CASH FLOWS FROM OPERATING ACTIVITIES:** |  |  |
| Net income (loss) | $728079 | $(119976) |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 559525 | 220633 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accretion of asset retirement obligation | 38967 | 36541 |
| &nbsp;&nbsp;&nbsp;&nbsp;Noncash operating lease expense | 244510 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | 832297 | 300847 |
| &nbsp;&nbsp;&nbsp;&nbsp;(Gain) loss on sale or disposal of property, plant and equipment, net | (500) | 17494 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accretion of income from investment securities held to maturity | (95990) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Write-down of inventory to net realizable value |  | 10501 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in allowance for credit losses | 884 | (14258) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other noncash items |  | (16106) |
| Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | (1387733) | (800182) |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | (5566803) | 913254 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | (1249047) | (203722) |
| &nbsp;&nbsp;&nbsp;&nbsp;IVA receivable and other assets, net | (483360) | 32758 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 4201001 | 217972 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | (175368) | 38283 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities – directors | (52537) | 36439 |
| &nbsp;&nbsp;&nbsp;&nbsp;Royalties payable | 49089 | (39512) |
| Net cash (used in) provided by operating activities | (2356986) | 630966 |
| **CASH FLOWS FROM INVESTING ACTIVITIES:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from redemption of certificates of deposit |  | 50682 |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of investment securities held to maturity | (9991259) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales of property, plant and equipment | 500 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of property, plant and equipment | (7394073) | (150721) |
| Net cash used in investing activities | (17384832) | (100039) |
| **CASH FLOWS FROM FINANCING ACTIVITIES:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Principal payments on long-term debt | (65550) | (39071) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from exercises of stock options | 55000 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of common stock, net of issuance costs | 5064483 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from exercise of warrants | 2225411 | - |
| Net cash provided by (used in) financing activities | 7279344 | (39071) |
| **NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH** | (12462474) | 491856 |
| CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD | 18270898 | 11954635 |
| **CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD** | $5808424 | $12446491 |
| **SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest paid in cash | $5243 | $2092 |
| **NON-CASH FINANCING AND INVESTING ACTIVITIES:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Recognition of operating lease liability and right-of-use asset | $63416 | $- |
| &nbsp;&nbsp;&nbsp;&nbsp;Equipment purchased with note payable | $- | $402722 |

---

The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.

---

| |
|:---|
| 6 |
| *[**Table of Contents**](#TOC)* |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)**

**<u>June 30, 2025</u>**

**NOTE 1 - NATURE OF OPERATIONS**

United States Antimony Corporation and its subsidiaries in the U.S., Mexico, and Canada ("USAC," the "Company," "Our," "Us," or "We") sell antimony, zeolite, and precious metals primarily in the U.S. and Canada. The Company processes third party ore primarily into antimony oxide, antimony metal, antimony trisulfide, and precious metals, primarily gold and silver, at its facilities located in Montana and Mexico. Antimony oxide is used to form a flame-retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper, as a color fastener in paint, and as a phosphorescent agent in fluorescent light bulbs. Antimony metal is used in bearings, storage batteries, and ordnance. Antimony trisulfide is used as a primer in ammunition. At its Bear River Zeolite ("BRZ") facility located in Idaho, the Company mines and processes zeolite, a group of industrial minerals used in water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation, animal nutrition, soil amendment and fertilizer, and other miscellaneous applications. In 2024 and 2025, the Company leased a metals concentration facility located in Montana and began acquiring mining claims and leases located in Alaska, Montana and Ontario, Canada, in an effort to expand its operations as well as its product offerings.

**NOTE 2 - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES**

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of its financial position as of June 30, 2025, and its results of operations and cash flows for the three and six months ended June 30, 2025 and 2024. The Condensed Consolidated Balance Sheet as of December 31, 2024, was derived from audited annual financial statements but does not contain all of the footnote disclosures from the annual financial statements.

These unaudited interim financial statements have been prepared by management in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). These unaudited interim financial statements should be read in conjunction with the annual audited financial statements included in the Company's Annual Report on Form 10-K/A for the year ended December 31, 2024, filed with the Securities and Exchange Commission on April 18, 2025.

This summary of significant accounting policies of the Company is presented to assist in understanding the Company's financial statements. These accounting policies conform to U.S. GAAP and have been consistently applied in the preparation of the financial statements.

<u>Use of Estimates</u>

The preparation of financial statements in accordance with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities known to exist as of the date the financial statements are published, and the reported amounts of revenues and expenses during the reporting period. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of the Company's consolidated financial statements; accordingly, it is possible that the actual results could differ from these estimates and assumptions, which could have a material effect on the reported amounts of the Company's consolidated financial position and results of operations. Operating results for the three and six months ended June 30, 2025, are not necessarily indicative of the results that may be expected for the full year ending December 31, 2025.

<u>Reclassifications</u>

Certain reclassifications have been made to conform prior period amounts to the current period's presentation. These reclassifications have no effect on the results of operations, stockholders' equity or cash flows as previously reported.

---

| |
|:---|
| 7 |
| *[**Table of Contents**](#TOC)* |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)**

**<u>June 30, 2025</u>**

<u>Investment Securities Held to Maturity</u>

The Company purchased short-term and long-term investment grade U.S. Treasury Strips in the second quarter of 2025 in an effort to protect itself from anticipated interest rate drops. These securities are classified as held-to-maturity and carried at amortized cost because the Company has both the intent and ability to hold them until their contractual maturity date. Since these U.S. Treasury Strips are zero-coupon instruments that do not pay periodic interest, the original investment amount is adjusted for the accretion of discounts using the effective interest method over the period from acquisition to maturity. Discount accretion is recognized as "Interest and investment income" in the Condensed Consolidated Statements of Operations.

Consistent with the Company's classification of its U.S. Treasury Strips as held to maturity, those securities scheduled to mature in the next twelve months after the reporting date are considered current assets and those having maturity dates more than twelve months after the applicable reporting date are considered non-current assets. Unrealized gains and losses on held-to-maturity securities are not recognized in the Company's condensed consolidated financial statements. Instead, these amounts are closely monitored and disclosed in the footnotes to the condensed consolidated financial statements.

The Company accounts for credit losses on its held-to-maturity securities in accordance with the expected credit loss model, as prescribed by U.S. GAAP. An allowance for credit losses is recognized to reflect the Company's estimate of expected credit losses over the contractual life of its held-to-maturity securities. In accordance with the accounting guidance prescribed for credit losses on held-to-maturity debt securities, the Company has presumed the expected credit losses on its U.S. Treasury Strips are negligible since they are explicitly guaranteed by the U.S. government.

<u>Recent Accounting Pronouncements</u>

In December 2023, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") 2023-09, Income Taxes (Topic 740): Improvement to Income Tax Disclosures, amending income tax disclosure requirements for the effective tax rate reconciliation and income taxes paid. The amendments in this ASU are effective for fiscal years beginning after December 15, 2024 and are applied prospectively. Early adoption and retrospective application of the amendments are permitted. These new disclosure requirements will be effective in the Company's Annual Report on Form 10-K for the fiscal year ending December 31, 2025. Other than the new disclosure requirements, this guidance is not expected to have an impact on the Company's consolidated financial statements.

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires disclosure about the types of costs and expenses included in certain expense captions presented on the income statement. These new disclosure requirements are effective for the Company's annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted, and may be applied either prospectively or retrospectively. The Company is currently evaluating the potential impact this update will have on its consolidated financial statements and expense disclosures in the notes to the consolidated financial statements.

The Company does not believe that issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company's financial statements.

---

| |
|:---|
| 8 |
| *[**Table of Contents**](#TOC)* |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)**

**<u>June 30, 2025</u>**

**NOTE 3 – EARNINGS PER SHARE**

Basic earnings per share ("EPS") is computed as net income (loss) available to common stockholders divided by the weighted average number of common shares outstanding for the period. Diluted EPS is calculated the same as Basic EPS but reflects the potential dilution that could occur from common shares issuable through stock options, restricted stock units ("RSUs"), and warrants in the weighted average number of common shares outstanding. Each stock option, RSU, and warrant represents the right to receive one share of the Company's common stock.

The following table sets forth the calculation of basic and diluted weighted average shares outstanding and net income (loss) per share for the periods presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Numerator: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | $181555 | $202792 | $728079 | ($119976) |
| &nbsp;&nbsp;&nbsp;&nbsp;Preferred dividends | (1875) | (1875) | (3750) | (3750) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) available to common shareholders | $179680 | $200917 | $724329 | $(123726) |
| Denominator: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted average shares - basic | 118261366 | 108438984 | 115994982 | 108173645 |
| &nbsp;&nbsp;&nbsp;&nbsp;Add - dilutive effect of stock options | 2499367 |  | 2412816 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Add - dilutive effect of RSUs | 1210001 | 504142 | 1150838 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Add - dilutive effect of warrants | 5252701 | - | 4784999 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted average shares - diluted | 127223435 | 108943126 | 124343635 | 108173645 |
| Net income (loss) per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $nil | $nil | $0.01 | $nil |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $nil | $nil | $0.01 | $nil |

---

The potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share as their effect would have been anti-dilutive were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Warrants |  | 12346215 |  | 12346215 |
| Stock options and RSU awards | 1897034 | 3945000 | 1997034 | 5778333 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total possible share dilution | 1897034 | 16291215 | 1997034 | 18124548 |

---

---

| |
|:---|
| 9 |
| *[**Table of Contents**](#TOC)* |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)**

**<u>June 30, 2025</u>**

**NOTE 4 – FAIR VALUE MEASUREMENTS**

The Company uses the fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price, based on the highest and best use of the asset or liability. The levels of the fair value hierarchy are:

Level 1—Quoted market prices in active markets for identical assets or liabilities;

Level 2—Significant other observable inputs (i.e., quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable, such as interest rate and yield curves, and market-corroborated inputs); and

Level 3—Unobservable inputs in which there is little or no market data, which require the reporting unit to develop its own assumptions.

The classification of fair value measurements within the established three-level hierarchy is based upon the lowest level of input that is significant to the measurements. Financial instruments, although not recorded at fair value on a recurring basis, include cash and cash equivalents, held-to-maturity securities, and debt obligations.

The carrying amounts of cash and cash equivalents approximate fair value because of its short-term nature. The estimated fair values of investment securities held to maturity were based on Level 2 inputs. The fair value of the Company's debt is estimated to be face value based on the contractual terms of the underlying debt arrangements and market-based expectations.

**NOTE 5 – REVENUE RECOGNITION**

The Company's products consist of the following:

· Antimony: includes antimony oxide, antimony metal, antimony trisulfide.

· Zeolite: includes coarse and fine zeolite crushed in various sizes.

· Precious metals: includes unrefined and refined gold and silver.

Sales by product type for the three and six months ended June 30, 2025 and 2024 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Antimony | $9636842 | $2663975 | $15562690 | $5133037 |
| Zeolite | 888281 | 994386 | 1982977 | 1597391 |
| Precious metals | - | 4616 | (20539) | 4616 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total revenues | $10525123 | $3662977 | $17525128 | $6735044 |

---

Domestic and foreign revenues for the three and six months ended June 30, 2025 and 2024 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended June 30,**  | **Three Months Ended June 30,**  | **Six Months Ended June 30,**  | **Six Months Ended June 30,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| Domestic | $10344931 | $2796962 | $17246258 | $5318413 |
| Canada | 180192 | 644957 | 278870 | 1195573 |
| Mexico | - | 221058 | - | 221058 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total revenues | $10525123 | $3662977 | $17525128 | $6735044 |

---

---

| |
|:---|
| 10 |
| *[**Table of Contents**](#TOC)* |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)**

**<u>June 30, 2025</u>**

The Company's trade accounts receivable balance related to contracts with customers was $2,543,413 at June 30, 2025 and $1,156,564 at December 31, 2024, which is net of an allowance for credit losses of $11,049 and $10,165 at June 30, 2025 and December 31, 2024, respectively. The Company's products do not involve any warranty agreements and product returns are not typical.

**NOTE 6 – INVESTMENT SECURITIES HELD TO MATURITY**

In April 2025, the Company purchased $9,991,259 of U.S. Treasury Strips with maturities ranging from approximately 12 to 54 months. These U.S. Treasury Strips are scheduled to mature approximately equally about every six months beginning in May 2026 and will generate interest yields of approximately 4%.

The Company has classified these securities as held-to-maturity because it has the intent and ability to hold them until their contractual maturity date. As a result, these securities are carried at amortized cost, which represents the original investment amount adjusted for the amortization of discounts using the effective interest method over the period from acquisition to maturity.

The following is a summary of the Company's investment securities held to maturity as of June 30, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Amortized** <br>**Cost** | **Gross** <br>**Unrealized** <br>**Gains** | **Gross** <br>**Unrealized** <br>**Losses** | **Estimated** <br>**Fair** <br>**Value** |
| Investment securities held to maturity - current: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Treasury Strips | $1258665 | $- | $(117) | $1258548 |
| Investment securities held to maturity - noncurrent: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Treasury Strips | 8828584 | 37152 | - | 8865736 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total investment securities held-to-maturity | $10087249 | $37152 | $(117) | $10124284 |

---

The Company recognized interest income accretion on its U.S. Treasury Strips of $95,990 during both the three and six months ended June 30, 2025. There were no investment securities outstanding at December 31, 2024 or held during the six months ended June 30, 2024.

Consistent with the Company's classification of its U.S. Treasury Strips as held to maturity, those securities scheduled to mature in the next twelve months after the reporting date are considered current assets and those having maturity dates more than twelve months after the reporting date are considered non-current assets. At June 30, 2025, the Company's held to maturity securities were scheduled to mature as follows:

---

| | | |
|:---|:---|:---|
| **Twelve months ending June 30,**  | **Amortized**<br>**Cost** | **Estimated**<br>**Fair**<br>**Value** |
| 2026 | $1258665 | $1258548 |
| 2027 to 2029 | 8828584 | 8865736 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total investment securities held to maturity | $10087249 | $10124284 |

---

<u>Line of Credit</u>

The Company secured a $5,000,000 line of credit facility ("LOC") in April 2025, which bears interest at one percent above the base commercial rate. The Company's investment securities serve as collateral for the LOC on which the Company had no outstanding borrowings at June 30, 2025.

---

| |
|:---|
| 11 |
| *[**Table of Contents**](#TOC)* |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)**

**<u>June 30, 2025</u>**

**NOTE 7 – INVENTORIES**

Inventories at June 30, 2025 and December 31, 2024 consisted primarily of finished antimony metal and antimony oxide products, antimony ore and concentrates, and finished zeolite products. Inventories are stated at the lower of first-in, first-out cost or estimated net realizable value. Finished antimony products and finished zeolite products primarily include direct materials, direct labor, overhead, depreciation, and freight. Inventories at June 30, 2025 and December 31, 2024 were as follows:

---

| | | |
|:---|:---|:---|
|  | **June 30,** <br>**2025** | **December 31,** <br>**2024** |
| Antimony oxide | $287704 | $254372 |
| Antimony metal | 1888290 | 154590 |
| Antimony ore and concentrates | 4251723 | 335588 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total antimony inventory | 6427717 | 744550 |
| Zeolite | 384810 | 501174 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total inventories | $6812527 | $1245724 |

---

At June 30, 2025 and December 31, 2024, inventories were valued at cost, except for the portion of inventory related to zeolite at December 31, 2024, which was valued at net realizable value because costs were greater than the amount the Company expected to receive upon the sale of the inventory. The adjustment to value zeolite inventory at net realizable value was $65,647 at December 31, 2024.

Antimony oxide, metal, and ore and concentrates were held primarily at the Company's plants located in Montana and Mexico. Some antimony metal is used in processing antimony ore into antimony oxide. Zeolite inventory was held at the Company's plant located in Idaho.

**NOTE 8 – PROPERTY, PLANT AND EQUIPMENT**

The major components of the Company's property, plant and equipment ("PP&E") by segment at June 30, 2025 and December 31, 2024 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **June 30, 2025** | **Antimony** | **Zeolite** | **All Other** | **TOTAL** |
| Plant and equipment | $13730854 | $6629086 | $469320 | $20829260 |
| Buildings | 1106303 | 1705893 | 456970 | 3269166 |
| Mineral rights and interests | 230000 | 16753 | 5504863 | 5751616 |
| Land | 2083094 |  | 914443 | 2997537 |
| Construction in progress | 996878 | 97634 | - | 1094512 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total property, plant and equipment | 18147129 | 8449366 | 7345596 | 33942091 |
| Accumulated depreciation | (9941059) | (4007975) | (267062) | (14216096) |
| &nbsp;&nbsp;&nbsp;&nbsp;Property, plant and equipment, net | $8206070 | $4441391 | $7078534 | $19725995 |
| **December 31, 2024** | **Antimony** | **Zeolite** | **All Other** | **TOTAL** |
| Plant and equipment | $13512321 | $6597781 | $427720 | $20537822 |
| Buildings | 1106303 | 1705893 | 11970 | 2824166 |
| Mineral rights and interests |  | 16753 | 125000 | 141753 |
| Land | 2083094 |  | 914443 | 2997537 |
| Construction in progress | - | 101938 | - | 101938 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total property, plant and equipment | 16701718 | 8422365 | 1479133 | 26603216 |
| Accumulated depreciation | (9602469) | (3857785) | (251515) | (13711769) |
| &nbsp;&nbsp;&nbsp;&nbsp;Property, plant and equipment, net | $7099249 | $4564580 | $1227618 | $12891447 |

---

---

| |
|:---|
| 12 |
| *[**Table of Contents**](#TOC)* |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)**

**<u>June 30, 2025</u>**

In February 2025, the Company purchased a personal residence located near its operations in Thompson Falls, Montana for $445,000, which is presently being used by management personnel that were transferred there and are now working in Montana predominantly on our expansion efforts. This asset and related expenses are included in the "All Other" category in the Company's segment reporting.

<u>Mineral rights and interests</u>

In January 2025, the Company executed an agreement to acquire the ownership rights to one hundred and twenty mining claims located in the Fairbanks District of Alaska ("January Fairbanks Agreement"). Payments to acquire these claims have been or will be made by the Company on or around the payment dates indicated as follows:

---

| | |
|:---|:---|
| **Payment Date** | **Payment Amount** |
| January 2025 | $100000 |
| July 2025 | 50000 |
| January 2026 | 50000 |
| July 2026 | 50000 |
| January 2027 | 50000 |
| July 2027 | 50000 |
| January 2028 | 50000 |
| July 2028 | 50000 |
| January 2029 | 100000 |
| July 2029 | 100000 |
| January 2030 | 100000 |
| July 2030 | 2250000 |
| Total | $3000000 |

---

The January Fairbanks Agreement requires a royalty payment by the Company based on the actual production from the claims ("Net Smelter Royalty on Claims") and another royalty payment by the Company based on the actual production, if any, from certain areas surrounding these one hundred and twenty mining claims ("Net Smelter Royalty on Surrounding Area"). A certain percentage of the Net Smelter Royalty on Claims can be purchased back by the Company with certain factors causing an escalation in this buyback amount. Also, the January Fairbanks Agreement includes a commitment by the Company to spend an aggregate of $2,250,000 on exploring and developing these claims over five years beginning January 2025, with various milestones over this five-year period. The January Fairbanks Agreement can be terminated without cause at any time by the Company with notice.

---

| |
|:---|
| 13 |
| *[**Table of Contents**](#TOC)* |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)**

**<u>June 30, 2025</u>**

In March 2025, the Company executed an agreement to acquire the ownership rights to twenty-five additional mining claims and leases located in the Fairbanks District of Alaska ("March Fairbanks Agreement"). Payments to acquire these claims and leases have been or will be made by the Company on or around the payment dates indicated as follows:

---

| | |
|:---|:---|
| **Payment Date** | **Payment Amount** |
| March 2025 | $50000 |
| September 2025 | 25000 |
| March 2026 | 25000 |
| March 2027 | 25000 |
| March 2028 | 25000 |
| March 2029 | 275000 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total | $425000 |

---

The March Fairbanks Agreement requires a royalty payment by the Company based on the actual production from the claims and leases ("Net Smelter Royalty"). A certain percentage of the Net Smelter Royalty can be purchased back by the Company. Also, the March Fairbanks Agreement includes a commitment by the Company to spend an aggregate of $250,000 on exploring and developing these claims and leases over approximately forty-one months beginning March 2025, with various milestones over this period. The March Fairbanks Agreement can be terminated without cause by the Company with notice.

In May 2025, the Company paid $230,000 to acquire the surface rights related to its patented lode mining claim located in Thompson Falls, Montana.

In June 2025, the Company acquired property located in the Sudbury District of Ontario, Canada, which included 50 single-cell mining claims (the Fostung Properties) for $5,000,000. Direct transaction costs related to this acquisition totaled $25,120. In addition, the agreement requires the Company to pay a net smelter return royalty based on actual production from the property.

Effective June 1, 2025, the Company executed an agreement to acquire the ownership rights to various patented federal lode mining claims located in the Fairbanks District of Alaska ("June Fairbanks Agreement"). Payments to acquire these claims are scheduled to be made by the Company as follows:

---

| | |
|:---|:---|
| **Payment Date** | **Payment Amount** |
| Within 10 days of June 1, 2025 | $150000 |
| December 2025 | 100000 |
| June 2026 | 100000 |
| June 2027 | 100000 |
| June 2028 | 100000 |
| June 2029 | 1450000 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total | $2000000 |

---

---

| |
|:---|
| 14 |
| *[**Table of Contents**](#TOC)* |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)**

**<u>June 30, 2025</u>**

The June Fairbanks Agreement requires net smelter royalty payments be made by the Company based on actual production from the claims. Also, the agreement includes a commitment by the Company to spend an aggregate of $700,000 in exploring and developing these claims based on various milestones scheduled to occur over approximately thirty-nine months from the effective date of the agreement. This agreement can be terminated without cause at any time by the Company with ninety-days' notice.

The payments made to acquire these mining claims and leases, including any direct transaction costs, are capitalized in the "Mineral rights and interests" component of "Property, plant and equipment, net" in the Condensed Consolidated Balance Sheets and included in the "All Other" category for segment reporting.

**NOTE 9 – LEASES**

<u>Philipsburg Operating Lease</u>

In September 2024, the Company executed a contract to lease a metals concentration facility located in Philipsburg, Montana. The Company amended this lease in March 2025 extending the term of the lease to September 2, 2026 and modifying the fixed monthly lease payments to $10,000 per month through the month of June 2025, $20,000 per month during the months of July 2025 to October 2025, and $95,000 per month thereafter to the end of the lease term. The $95,000 per month payment includes a fixed monthly fee of $45,000 and a minimum milling fee of $50,000 per month. An additional payment of $50 per ton is due each month in the last twelve months of the lease for all milling in excess of 1,000 tons per month. The Company has not included any milling fee payments above the minimum in its lease liability as it is not deemed probable at this time. The Company recorded the present value of the original fixed lease cost in September 2024 over the lease term as a lease liability and Right of Use ("ROU") asset. As a result of the amendment in March 2025, the Company reduced the ROU asset and corresponding lease liability by $37,448. The Company used its incremental borrowing rate of 3.49% when determining the present value of future payments of this operating lease as the rate implicit in the lease was not readily determinable. The lease includes provisions for the Company to use the existing mill building and all contents related to its use and to process owned and non-owned ore containing antimony and other minerals. The lease does not include any transfer of ownership of the facility at the end of the lease, nor any option to extend the lease or purchase the facility, nor any residual value guarantees. The Company can terminate the lease without cause with thirty days' notice and must provide the facility to the lessor at the end of the lease in the same condition as it was received.

The lease liability related to this operating lease, which represents the present value of the lease payments, was $701,557 at inception of the lease amendment and $664,817 and $755,569 at June 30, 2025 and December 31, 2024, respectively. The ROU asset, which includes the unamortized portion of initial direct costs ("IDC") and is adjusted for any accrued or prepaid lease, was $230,027 and $565,289 at June 30, 2025 and December 31, 2024, respectively. During the three and six months ended June 30, 2025, the Company recorded $127,548 and $304,510, respectively, of lease expense related to this lease and IDC in "Cost of Revenues" in the Condensed Consolidated Statements of Operations. Lease payments were $40,000 and $70,000 during the three and six months ended June 30, 2025, respectively, which were included in operating cash flows. For the three and six months ended June 30, 2024, there were no payments made or expense recorded for this lease.

<u>Dallas Operating Lease</u>

In the first quarter of 2025, the Company executed a contract to lease office space for its corporate headquarters located in Dallas, Texas with a lease term of 24 months and total fixed payments during the term of $3,945 per month, or $94,680 in total. The Company is amortizing the lease on a straight-line basis over the term of the lease. The Company recorded the present value of the lease payments over the term as a lease liability and ROU asset. The Company's incremental borrowing rate of 3.49% was used as the discount rate as the rate implicit in the lease was not readily determinable. The lease does not include any transfer of ownership of the office space at the end of the lease, nor any option to extend the lease or purchase the facility, nor any residual value guarantees. The Company cannot terminate the lease without cause and must provide the office space to the lessor at the end of the lease in the same condition as it was received.

---

| |
|:---|
| 15 |
| *[**Table of Contents**](#TOC)* |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)**

**<u>June 30, 2025</u>**

The lease liability related to this operating lease, which represents the present value of the lease payments, and ROU asset were $63,416 at inception of the lease and $45,600 and $nil at June 30, 2025 and December 31, 2024, respectively. During the three and six months ended June 30, 2025, the Company recorded $11,835 and $19,725, respectively, of lease expense related to this lease in "General and administrative" in the Condensed Consolidated Statements of Operations. Lease payments were $11,835 and $19,725 during the three and six months ended June 30, 2025, respectively, which were included in operating cash flows. The Company made a security deposit payment of $3,945 at the inception of the lease. For the three and six months ended June 30, 2024, there were no payments made or expense recorded for this lease.

The following table summarizes expense and cash payments for both operating leases during the periods noted:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended June 30,**  | **Three months ended June 30,**  | **Six months ended June 30,**  | **Six months ended June 30,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| Operating lease expense | $139383 | $- | $324235 | $- |
| Cash paid for operating lease liability | 51835 |  | 89725 |  |
| Cash paid for security deposit |  |  | 3945 |  |

---

At June 30, 2025, the weighted average remaining lease term of operating leases was 14 months and the weighted average discount rate for operating leases was 3.49%.

The following table is a maturity analysis of the future minimum lease payments for operating leases as of June 30, 2025:

---

| | |
|:---|:---|
| **Twelve months ending June 30,** |  |
| 2026 | $887340 |
| 2027 | 217615 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating lease payments | 1104955 |
| Less: discount on lease liability | (394538) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating lease liability | 710417 |
| Less: current portion of operating lease liability | (592695) |
| &nbsp;&nbsp;&nbsp;&nbsp;Noncurrent operating lease liability | $117722 |

---

**NOTE 10 – LONG-TERM DEBT**

Long-term debt at June 30, 2025 and December 31, 2024 was as follows:

---

| | | |
|:---|:---|:---|
|  | June 30, <br>2025 | December 31, <br>2024 |
| Installment contract payable to Komatsu, bearing interest at 3.49%, payable in 36 monthly installments of $11,799 maturing May 2027; collateralized by the Wheel Loader | $262127 | $327677 |
| Less current portion of debt | (134577) | (132252) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term debt, net | $127550 | $195425 |

---

At June 30, 2025, principal payments on debt were due as follows:

---

| | |
|:---|:---|
| **Twelve months ending June 30,** | **Total** |
| 2026 | $134577 |
| 2027 | 127550 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $262127 |

---

---

| |
|:---|
| 16 |
| *[**Table of Contents**](#TOC)* |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)**

**<u>June 30, 2025</u>**

**NOTE 11 – INCOME AND OTHER TAXES**

Management estimates that the Company's 2025 effective tax rate will be 0% due to the Company's cumulative loss position, historical net operating losses, and other available evidence related to the Company's ability to generate taxable income. Accordingly, there is no income tax expense or benefit recorded for the three- and six-month periods ended June 30, 2025.

<u>Mexico Tax Assessment</u>

In 2015, the Mexican tax authority ("SAT") initiated an audit of the U.S. Antimony de Mexico, S.A. de C.V. ("USAMSA") 2013 income tax return. In October 2016, as a result of its audit, SAT assessed the Company $13.8 million pesos, which was approximately $666,400 in U.S. Dollars ("USD") as of December 31, 2016. SAT's assessment was based on the disallowance of specific costs that the Company deducted on the 2013 USAMSA income tax return. The assessment was settled in 2018 with no assessment due from the Company.

In 2019, the Company was notified that SAT re-opened its assessment of USAMSA's 2013 income tax return and, in November 2019, SAT assessed the Company $16.3 million pesos, which was approximately $865,000 USD as of December 31, 2019. Management reviewed the 2019 assessment notice from SAT and, similar to the earlier assessment, believed the findings have no merit. An appeal was filed by the Company in November 2019 suspending SAT from taking immediate action regarding the assessment. In August 2020, the Company filed a lawsuit against SAT for resolution of the process and, in December 2020, filed closing arguments. In 2022, the Mexican court ruled against the Company in the above matter, which was subsequently appealed by the Company.

As of December 31, 2023, the updated SAT assessment was approximately $22.4 million pesos, or approximately $1,320,000 USD, which includes $352,000 of unpaid income taxes and $968,000 of interest and penalties. Management, along with its legal counsel, assessed the possible outcomes for this tax audit and believed, based on discussions with its attorneys located in Mexico, that the most likely outcome would be that the Company would be successful in its appeal resulting in no tax due. Management determined that no amount should be accrued at December 31, 2023 relating to this potential tax liability.

In March 2024, Mexico's appellate court ruled in favor of the Company with no assessment due related to this audit of USAMSA's 2013 income tax return by SAT and instructed the lower court to issue a new ruling. In May 2024, Mexico's lower court issued a final ruling on this matter in favor of the Company but left open the possibility for the SAT to re-open their audit. Subsequent to this judgment, the Company requested a final ruling on whether SAT can re-open this matter, on which the appellate court has not ruled. These rulings support the Company's position on this tax matter and have had no impact on the Company's financial statements.

<u>Mexico Import Value Added Tax</u>

USAMSA has a receivable of $1,346,690 and $907,408 at June 30, 2025 and December 31, 2024, respectively, related to Import Value Added Tax ("IVA tax" or "VAT") it pays on certain goods and services, which represents the amounts to be reimbursed from the Mexican government. USAMSA also has established an allowance for estimated uncollectible amounts associated with this IVA tax receivable of $785,018 and $575,151 at June 30, 2025 and December 31, 2024, respectively. The net IVA tax receivable of $561,672 and $332,257 at June 30, 2025 and December 31, 2024, respectively, is recorded in "IVA receivable and other assets, net" in the Condensed Consolidated Balance Sheets.

---

| |
|:---|
| 17 |
| *[**Table of Contents**](#TOC)* |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)**

**<u>June 30, 2025</u>**

**NOTE 12 – COMMITMENTS AND CONTINGENCIES**

Historically, BRZ has from time to time been assessed fines and penalties by the Mine Safety and Health Administration ("MSHA"). During the six months ended June 30, 2025, BRZ received three citations from MSHA, one of which was significant and substantial. All three citations were rectified by BRZ and terminated by MSHA on the day the citations were issued. At June 30, 2025 and December 31, 2024, BRZ had "accrued liabilities" in the Condensed Consolidated Balance Sheets of $4,827 and $19,074, respectively, relating to MSHA citations.

BRZ has a lease with Zeolite, LLC that entitles BRZ to surface mine and process zeolite on property in Preston, Idaho, in exchange for an annual payment and a royalty payment, which is based on the amount of zeolite shipped from the leased property ("BRZ Lease"). In February 2025, the Company extended the BRZ Lease through December 31, 2034 with similar terms and conditions as the prior agreement.

In April 2025, the Company began contracting for engineering and construction services to expand its existing smelting operations located in Thompson Falls, Montana. Total capital expenditures associated with the expansion plans are estimated to be approximately $17,000,000 of which approximately $4,500,000 has been formally agreed to with various third-party vendors.

**NOTE 13 – STOCKHOLDERS' EQUITY**

<u>Issuance of Common Stock</u>

During the six months ended June 30, 2025 and 2024, the Company issued 1,472,097 shares and 791,667 shares, respectively, of its common stock in conjunction with the vesting of restricted stock units ("RSUs") and exercising of stock options. See the "Share-Based Compensation" section below for further details.

<u>Sale of Common Stock</u>

During the six months ended June 30, 2025, the Company sold 1,857,923 shares of its common stock in an "at the market offering" and received gross proceeds of $5,158,787 based on a weighted average price of $2.78 per share. Direct issuance costs totaling $94,304 were incurred related to these sales. The Company did not sell any of its common stock during the six months ended June 30, 2024.

The Company also issued 2,919,643 shares of its common stock in the first six months of 2025 related to the exercise of pre-existing warrants. See the "Common Stock Warrants" section below for further details.

<u>Share-based compensation</u>

In December 2023, the shareholders of the Company approved our 2023 Equity Incentive Plan ("the Plan"), which provides for the grant of incentive stock options, non-qualified stock options and other types of awards. The general purpose of the Plan is to provide a means whereby eligible employees, officers, directors and other service providers develop a sense of proprietorship and personal involvement in our development and financial success, and to encourage them to devote their best efforts to our business, thereby advancing our interests and the interests of our shareholders. During the six months ended June 30, 2025, the Company granted stock options and RSUs totaling 757,300 and 654,600, respectively, pursuant to the Plan. Once vested, each stock option and RSU represent the right to receive one share of the Company's common stock. The maximum number of shares of common stock available for issuance in connection with stock options, RSUs, and other awards granted under the Plan is 8,700,000.

---

| |
|:---|
| 18 |
| *[**Table of Contents**](#TOC)* |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)**

**<u>June 30, 2025</u>**

Share-based compensation expense for the periods noted was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Stock options | $251571 | $47558 | $404083 | $63469 |
| RSUs | 335342 | 47364 | 428214 | 237378 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total share-based compensation expense | $586913 | $94922 | $832297 | $300847 |

---

The following table summarizes the aggregate non-cash stock-based compensation recognized in the Condensed Consolidated Statement of Operations for stock options and RSUs:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| General and administrative | $263385 | $67708 | $331093 | $227777 |
| Salaries and benefits | 319627 | 27214 | 493403 | 73070 |
| Professional fees | 3901 | - | 7801 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Total non-cash share-based compensation expense | $586913 | $94922 | $832297 | $300847 |

---

**Stock options**

Stock options granted have either a 3-year or 10-year contractual term and are subject to either service or performance-based vesting conditions. The following table summarizes the weighted-average assumptions used to value stock options granted during the six months ended June 30, 2025 using the Black-Scholes method:

---

| | |
|:---|:---|
| **Weighted-Average Grant Date Assumptions** | **Six Months Ended** <br>**June 30, 2025** |
| Expected term (in years) | 8.3 |
| Risk-free interest rate | 4.4% |
| Expected dividend yield | 0.0% |
| Expected volatility | 97.0% |
| Fair value per share | $1.80 |

---

*Expected term* – The expected term represents the period of time that options are expected to be outstanding. As the Company does not have sufficient historical exercise behavior, it uses the contractual term of the option or the simplified method as defined in Staff Accounting Bulletin Topic 14 for the expected term assumption.

*Risk-free interest rate* – The risk-free interest rate is based on the U.S. Treasury rate in effect at the time of the grant with an equivalent term approximating the expected term of the options.

*Expected dividend yield*—The Company bases the expected dividend yield assumption on the fact that it has never paid cash dividends and has no present intention to pay cash dividends.

*Expected volatility* – The expected volatility is based on the historical volatility of our stock price over the expected term of the stock option.

---

| |
|:---|
| 19 |
| *[**Table of Contents**](#TOC)* |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)**

**<u>June 30, 2025</u>**

Activity with respect to stock options is summarized as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Shares** | **Weighted-Average** <br>**Exercise** <br>**Price Per Share** | **Weighted-Average Remaining**<br> **Contractual** <br>**Term (in years)** | **Aggregate**<br> **Intrinsic** <br>**Value** |
| Options outstanding, December 31, 2024 | 4330000 | $0.23 | 3.7 | $6652700 |
| Granted | 757300 | 2.08 |  |  |
| Exercised | (622500) | 0.23 |  |  |
| Forfeited | (166667) | 0.22 |  |  |
| Expired | - | - | - | - |
| Options outstanding, June 30, 2025 | 4298133 | $0.56 | 4.4 | $7058358 |
| Nonvested options, June 30, 2025 | 3718966 | $0.61 | 4.6 | $5932566 |
| Vested and exercisable options, June 30, 2025 | 579167 | $0.24 | 3.7 | $1125792 |

---

At June 30, 2025, total unrecognized share-based compensation expense related to stock options was $1,496,779, which is expected to be recognized over a weighted-average remaining period of 1.9 years. During the six months ended June 30, 2025, 622,500 stock options were exercised to purchase shares of common stock. These exercises included 250,000 options for cash proceeds of $55,000 and cashless exercises where 50,269 shares of common stock were surrendered to the Company to pay for the aggregate exercise price of the stock options and 322,231 shares of common stock were issued. The total intrinsic value of the 622,500 stock options exercised during the six months ended June 30, 2025 was $1,061,033.

**Restricted stock units**

Activity with respect to RSUs is summarized as follows:

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Weighted-Average** <br>**Grant Date** <br>**Fair Value** <br>**Per Share** |
| RSUs outstanding at December 31, 2024 | 2090000 | $0.24 |
| &nbsp;&nbsp;&nbsp;&nbsp;Granted | 654600 | 2.26 |
| &nbsp;&nbsp;&nbsp;&nbsp;Vested and issued | (899866) | 0.40 |
| &nbsp;&nbsp;&nbsp;&nbsp;Forfeited | - | - |
| RSUs outstanding at June 30, 2025 | 1844734 | 0.88 |

---

At June 30, 2025, total unrecognized share-based compensation expense related to RSUs was $1,382,688, which is expected to be recognized over a weighted-average remaining period of 2.1 years. The weighted-average remaining contractual term of the nonvested RSU shares was 1.4 years at June 30, 2025.

---

| |
|:---|
| 20 |
| *[**Table of Contents**](#TOC)* |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)**

**<u>June 30, 2025</u>**

<u>Common stock warrants</u>

During the first six months of 2025, the Company issued 2,919,643 shares of common stock related to the exercise of pre-existing warrants and received gross proceeds of $2,225,411, based on a weighted average exercise price of $0.76 per share. No warrants were issued or expired during the six months ended June 30, 2025 and 2024 nor were any warrants exercised during the six months ended June 30, 2024.

Following is a summary of the Company's warrant activity during the six months ended June 30, 2025:

---

| | | |
|:---|:---|:---|
|  | **Number of** <br>**Warrants** | **Weighted Average** <br>**Exercise Price** |
| Balance at December 31, 2024 | 10142215 | $0.77 |
| Exercised | (2919643) | 0.76 |
| Balance at June 30, 2025 | 7222572 | $0.77 |

---

Each warrant represents the right to receive one share of the Company's common stock. The composition of the Company's warrants outstanding at June 30, 2025 was as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Number of warrants** | **Exercise Price** | **Expiration Date** | **Remaining life (years)** |
| 1428572 | $0.46 | 1/27/2026 | 0.58 |
| 4987500 | $0.85 | 8/3/2026 | 1.09 |
| 806500 | $0.85 | 2/1/2026 | 0.59 |
| 7222572 |  |  |  |

---

All outstanding warrants of the Company expire on or before August 3, 2026.

**NOTE 14 – BUSINESS SEGMENTS**

The Company has two reportable segments: antimony and zeolite. Our antimony segment consists of:

· Our facility located in the Burns Mining District of Sanders County in Montana that processes ore primarily into antimony oxide, antimony metal, antimony trisulfide, and precious metals, and

· Our two facilities in our USAMSA subsidiary located in Mexico that process ore primarily into antimony metal, a lower grade of antimony oxide, and precious metals.

Our zeolite segment consists of our facility located in Preston, Idaho that mines, processes, and sells zeolite.

The following components of the Company's business do not currently engage in business activities from which they recognize revenue and incur expenses: Los Juarez, Mexico in our ADM subsidiary, Ontario, Canada, Alaska, Philipsburg, Montana, and the mining claims in Thompson Falls, Montana. Therefore, these components, along with the Company's personal residence in Thompson Falls, Montana, have been included in the "All Other" category for segment reporting. The Company's chief operating decision maker is its chief executive officer.

Total assets by segment at June 30, 2025 and December 31, 2024 were as follows:

---

| | | |
|:---|:---|:---|
| **Total Assets** | **June 30,**<br> **2025** | **December 31,** <br>**2024** |
| Antimony segment: | $34261561 | $27230312 |
| Zeolite segment | 5897295 | 5604003 |
| All other | 7339466 | 1808287 |
| Total assets | $47498322 | $34642602 |

---

---

| |
|:---|
| 21 |
| *[**Table of Contents**](#TOC)* |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)**

**<u>June 30, 2025</u>**

Total capital expenditures by segment for the three and six months ended June 30, 2025 and 2024 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended June 30,** | **Three months ended June 30,** | **Six months ended June 30,** | **Six months ended June 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Antimony segment | $1269129 | $- | $1445411 | $- |
| Zeolite segment | 25970 | 98008 | 82199 | 150721 |
| All other | 5236463 | - | 5866463 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Total capital expenditures | $6531562 | $98008 | $7394073 | $150721 |

---

Selected segment operational information for the three and six months ended June 30, 2025 and 2024 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **For the three months ended June 30, 2025** | **Antimony** | **Zeolite** | **All Other** | **Total** |
| Total revenues | $9636842 | $888281 | $- | $10525123 |
| Depreciation and amortization | 171040 | 98031 | 8484 | 277555 |
| Income (loss) from operations | 832735 | (122252) | (690476) | 20007 |
| Other income |  |  |  | 161548 |
| Income tax expense |  |  |  | - |
| Net income |  |  |  | $181555 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **For the three months ended June 30, 2024** | **Antimony** | **Zeolite** | **All Other** | **Total** |
| Total revenues | $2668591 | $994386 | $- | $3662977 |
| Depreciation and amortization | 19902 | 90560 | 4024 | 114486 |
| Income (loss) from operations | 548978 | (349805) | (143165) | 56008 |
| Other income |  |  |  | 146784 |
| Income tax expense |  |  |  | - |
| Net loss |  |  |  | $202792 |
| **For the six months ended June 30, 2025** | **Antimony** | **Zeolite** | **All Other** | **Total** |
| Total revenues | $15542151 | $1982977 | $- | $17525128 |
| Depreciation and amortization | 338591 | 205387 | 15547 | 559525 |
| Income (loss) from operations | 1976575 | (430028) | (1168548) | 377999 |
| Other income  |  |  |  | 350080 |
| Income tax expense |  |  |  | - |
| Net income  |  |  |  | $728079 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **For the six months ended June 30, 2024** | **Antimony** | **Zeolite** | **All Other** | **Total** |
| Total revenues | $5137653 | $1597391 | $- | $6735044 |
| Depreciation and amortization | 39697 | 172888 | 8048 | 220633 |
| Income (loss) from operations | 767769 | (1007134) | (175081) | (414446) |
| Other income  |  |  |  | 294470 |
| Income tax expense |  |  |  | - |
| Net income |  |  |  | ($119976) |

---

---

| |
|:---|
| 22 |
| *[**Table of Contents**](#TOC)* |

---

**UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)**

**<u>June 30, 2025</u>**

**Note 15 - SUBSEQUENT EVENTS**

<u>Sales of Common Stock</u>

In July 2025, the Company sold 1,522,340 shares of its common stock in an "at the market offering" and received gross proceeds of $5,405,126 based on a weighted average price of $3.55 per share. A total of $97,694 in direct issuance costs were incurred related to this sale.

<u>Letter of Credit</u>

In July 2025, the Company issued a letter of credit (the "LC") for approximately $1.8 million related to the purchase of antimony ore from an international supplier. This supplier will be paid for the ore it supplies via the LC if certain conditions are met. Approximately $1.8 million of the Company's cash was used as collateral for the LC.

<u>Amended and Restated 2023 Equity Incentive Plan</u>

On July 31, 2025, the Company's shareholders approved the Amended and Restated 2023 Equity Incentive Plan (the "Amended Plan") to increase the number of shares of common stock reserved for issuance under the Amended Plan from 8,700,000 shares to 23,700,000 shares, among other changes.

---

| |
|:---|
| 23 |
| *[**Table of Contents**](#TOC)* |

---

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION.**

**CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS**

Readers should note that, in addition to the historical information contained herein, this Quarterly Report and the exhibits attached hereto contain "forward-looking statements" within the meaning of, and intended to be covered by, the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based upon current expectations and beliefs concerning future developments and their potential effects on United States Antimony Corporation ("US Antimony," "USAC," or the "Company") including matters related to the Company's operations, pending contracts and future revenues, financial performance, and profitability, ability to execute on its increased production and installation schedules for planned capital expenditures, and the size of forecasted deposits. Although the Company believes that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, it can give no assurance that such expectations and assumptions will prove to have been correct. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always using words or phrases such as "believes," "expects" or "does not expect," "is expected," "outlook," "anticipates" or "does not anticipate," "plans," "estimates," "forecast," "project," "pro forma," or "intends," or stating that certain actions, events or results "may" or "could," "would," "might" or "will" be taken, occur or be achieved) are not statements of historical fact and may be forward-looking statements. Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made and are subject to assumptions and uncertainties. Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied by the forward-looking statements, including, without limitation, risks related to:

· The Company's properties being in the exploration stage;

· Macroeconomic factors;

· The imposition of new tariffs, changes in trade policy or agreements, or the escalation of trade tensions between the United States and other countries or regions could have a material adverse impact on our business;

· Continued operational losses;

· Negative consequences related to mineral operations being subject to existing and new government regulations within and outside the United States;

· The Company's ability to obtain additional capital to develop the Company's resources, if any;

· Concentration of customers;

· Increase in energy costs;

· Mineral exploration and development activities;

· Mineral estimates;

· The Company's insurance coverage for operating risks;

· The fluctuation of prices for antimony and precious metals, such as gold and silver;

· The competitive industry of mineral exploration;

· The title and rights in the Company's mineral properties;

· Environmental hazards;

· The possible dilution of the Company's common stock from additional financing activities;

· Metallurgical and other processing problems;

· Unexpected geological formations;

· Global economic and political conditions;

· Staffing in remote locations;

· Changes in product costing;

---

| |
|:---|
| 24 |
| *[**Table of Contents**](#TOC)* |

---

---

| |
|:---|
| Inflation on operational costs and profitability; |
| Competitive technology positions and operating interruptions (including, but not limited to, labor disputes, leaks, fires, flooding, landslides, power outages, explosions, unscheduled downtime, transportation interruptions, war and terrorist activities); |
| Global pandemics, natural disasters, or civil unrest; |
| Mexican labor and other issues regarding safety and organized control over our properties; |
| The positions and associated outcomes of Mexican and other taxing authorities; |
| Cybersecurity and business disruptions; |
| Ineffective use of cash and cash equivalents, including proceeds from stock offerings; |
| Potential conflicts of interest with the Company's management; |
| Mining exploration, development, and production not being economically viable; |
| Mineral reserve estimates, including those prepared by "Qualified Persons" (as defined by SEC Regulation S-K 1300), are not guarantees of the volume or grade of ore that will ultimately be recovered; |
| Processing and selling ore from new suppliers and internal sources not being economically viable; |
| More risk associated with non-domestic supply of antimony ore; and |
| Fluctuations in the Company's common stock. |

---

This list is not an exhaustive list of the factors that may affect the Company's forward-looking statements. Some of the important risks and uncertainties that could affect forward-looking statements are described further under the sections titled "Risk Factors," "Description of Business" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" of this Quarterly Report. If one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. The Company cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. United States Antimony Corporation disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events, except as required by law. The Company advises readers to carefully review this Form 10-Q, the exhibits hereto, and the reports and documents incorporated by reference herein and filed with the Securities and Exchange Commission (the "SEC").

You should read this report with the understanding that our actual future results, levels of activity, performance and events and circumstances may be materially different from what we expect and from our historical results.

This report contains estimates, projections and other information concerning our industry, our business and the markets for our products. We obtained the industry, market and similar data set forth in this report from our own internal estimates and research and from industry research, publications, surveys and studies conducted by third parties, including governmental agencies. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties, and actual events or circumstances may differ materially from events and circumstances that are assumed in this information. While we believe that the data we use from third parties is reliable, we have not separately verified this data. You are cautioned not to give undue weight to any such information, projections and estimates. As a result of a number of known and unknown risks and uncertainties, our actual results or performance may be materially different from those expressed or implied by forward-looking statements.

As used in this Quarterly Report, the terms "we," "us," "our," "United States Antimony Corporation,", "US Antimony," "USAC," and the "Company", mean United States Antimony Corporation, unless otherwise indicated. All dollar amounts in this Quarterly Report are expressed in U.S. dollars, unless otherwise indicated.

Management's Discussion and Analysis is intended to be read in conjunction with the Company's consolidated financial statements and the integral notes ("Notes") thereto included in the Company's Annual Report on Form 10-K/A for the fiscal year ended December 31, 2024.

---

| |
|:---|
| 25 |
| *[**Table of Contents**](#TOC)* |

---

**DESCRIPTION OF BUSINESS**

**History**

United States Antimony Corporation's principal business is the production and sale of antimony, precious metals, and zeolite products. The Company was incorporated in Montana in January 1970 to mine and produce antimony products. In December 1983, the Company suspended its antimony mining operations in the U.S. but continued to produce antimony products using foreign sources of antimony ore. In April 1998, the Company formed US Antimony de Mexico, S.A. de C.V. ("USAMSA") to produce antimony products in Mexico, and, in August 2005, the Company formed Antimonio de Mexico, S.A. de C.V. ("ADM") to explore and develop antimony and precious metal deposits in Mexico. The Company formed Bear River Zeolite Company ("BRZ") in 2000 for the purpose of mining and producing zeolite products in Idaho. In 2024, the Company leased a metals concentration facility with two flotation circuits located in Philipsburg, Montana. In 2024 and 2025, the Company acquired mining claims and leases located in Alaska, Montana and Ontario, Canada, which necessitated forming three entities related to the Alaska mining claims, Great Land Minerals, LLC, Denali Minerals, LLC, and Alaska Antimony LLC, and one entity related to the Ontario mining claims and leases, UAMY Cobalt Corporation. We expect these mining claims and leases will expand the Company's operations and product offerings. Currently, no active operations are being conducted, nor is any revenue being generated, from the Company's business components located in Los Juarez, Mexico (our ADM subsidiary), Ontario, Canada, Alaska, Philipsburg, Montana, and the mining claims in Thompson Falls, Montana. The Company is also considering the acquisition of additional property in Alaska to be used for operating activities, including ore separation and storage, as well as an office for its staff.

In May 2012, our shares of common stock started trading on the NYSE MKT exchange (now NYSE AMERICAN) under the symbol UAMY. On July 1, 2025, the Company's common stock also began trading on a new stock exchange, the NYSE Texas. The Company continues to maintain its primary listing on the NYSE American Stock Exchange and trades with the same "UAMY" ticker symbol on both exchanges.

On July 31, 2025, the Company's shareholders approved the conversion of the Company from a corporation organized under the laws of the State of Montana to a corporation organized under the laws of the State of Texas (the "Texas Reincorporation"). After the Texas Reincorporation is complete, the rights of the Company's shareholders previously governed by the Montana Business Corporation Act, as amended, and the Company's Articles of Incorporation and Bylaws in effect prior to the Texas Reincorporation, will be governed by the Texas Business Organizations Code and the Certificate and Bylaws filed and adopted by the Company under Texas law. The Texas Reincorporation will not result in any change in business, jobs, management, properties, location of any of our offices or facilities, number of employees, obligations, assets, liabilities or net worth. Also, the Company intends to maintain its corporate headquarters in Texas and does not expect there to be any interruption in the trading of its common stock. The Texas Reincorporation is expected to become effective as soon as practicable following the 2025 Annual Meeting.

The Company has two reportable segments: antimony and zeolite.

***Antimony Segment***

Our antimony segment consists of:

· Our facility located in the Burns Mining District of Sanders County in Montana that processes ore primarily into antimony oxide, antimony metal, antimony trisulfide, and precious metals, and

· Our two facilities in our USAMSA subsidiary located in Mexico that process ore primarily into antimony metal, a lower grade of antimony oxide, and precious metals.

Antimony is a mineral that is included in many products that are used every day, both by the military and by industrial customers. USAC can provide this mineral in a form that can be used in these products.

---

| |
|:---|
| 26 |
| *[**Table of Contents**](#TOC)* |

---

Antimony is used in many products as a fire-retardant and a primer and is on the Critical Minerals List of the U.S. Government. Antimony mined from the ground, which is called antimony ore or ore, is typically not salable as a finished product primarily due to impurities in the ore, the ore size not being compatible with its intended use, and the percentage of antimony contained in the ore being too low. We process ore to remove impurities, refine the size, and increase the percentage of antimony contained in the ore to approximately 71.4% to make the finished product called antimony trisulfide, to approximately 83% to make the finished product called antimony oxide, and to approximately 99.65% to make the finished product called antimony metal. Antimony trisulfide, oxide, and metal can be sold as finished products to companies in many industries as well as government agencies. Antimony oxide is used to form a flame-retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper, as a color fastener in paint, and as a phosphorescent agent in fluorescent light bulbs. Antimony metal is used in bearings, storage batteries, and ordnance. Antimony trisulfide is used as a primer in ammunition. The ore we purchase for our facility located in Montana contains antimony, gold, and silver. Our Montana facility processes this ore and typically sells the gold and silver to the company who sold us this ore, which represents all our precious metals sales, and sells the antimony to other companies in various industries. Our Mexico facilities have been processing ore primarily into antimony metal.

We estimate (but have not independently confirmed) that our present share of the domestic and international markets for antimony oxide products is approximately 4% and less than 1%, respectively. We believe we are competitive due to the following:

· We are the only U.S. domestic operating, permitted processor of antimony products.

· We can process ore quickly and have minimal shipping time to domestic customers.

· We have a reputation for quality products delivered on a timely basis.

· Our smelter in Coahuila, Mexico is the largest and only current operating smelter for the processing of antimony products in Mexico. 

***Zeolite Segment***

Our zeolite segment includes our vertically integrated Bear River Zeolite ("BRZ") facility located in Preston, Idaho that mines, processes, and sells zeolite. Zeolite is a mineral that is included in many products that are used every day. BRZ can provide these minerals in a form that can be used in these products. Our zeolite has been used for many purposes including water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation, animal nutrition, soil amendment and fertilizer, and other miscellaneous applications.

On July 24, 2025, the Company published a technical report summary on its zeolite mineral deposit located in Preston, Idaho. This Technical Report Summary, dated July 2, 2025 (the "TRS"), on the Bear River Zeolite Project was prepared in accordance with the mining property disclosure rules specified in subpart 1300 of Regulation S-K. The full text of the TRS is an exhibit to the Form 8-K filed by the Company on July 25, 2025.

BRZ has a lease with Zeolite, LLC that entitles BRZ to surface mine and process zeolite on the property in Preston, Idaho, in exchange for an annual payment and a royalty payment, which is based on the amount of zeolite shipped from the leased property ("BRZ Lease"). The BRZ Lease was recently extended and now ends on December 31, 2034. In addition, BRZ can surface mine and process zeolite on property owned by the U.S. Bureau of Land Management that is located adjacent to the Company's Preston, Idaho property after obtaining required permits.

"Zeolite" refers to a group of industrial minerals that consist of hydrated aluminosilicates that hold cations such as calcium, sodium, ammonium, various heavy metals, and potassium in their crystal lattice. Water is loosely held in cavities in the lattice. BRZ zeolite is regarded as one of the best zeolites in the world due to its high cation exchange capacity (CEC) of approximately 180-220 meq/100 gr. (which predicts plant nutrient availability and retention in soil), its hardness and high clinoptilolite content (which is an effective barrier to prevent problematic radionuclide movement), its absence of clay minerals, and its low sodium content. Our zeolite has been used in:

---

| |
|:---|
| 27 |
| *[**Table of Contents**](#TOC)* |

---

☐ <u>Soil Amendment and Fertilizer</u>. Zeolite has been successfully used to fertilize golf courses, sports fields, parks and common areas, and high value agricultural crops.

☐ <u>Water Filtration</u>. Zeolite is used for particulate, heavy metal and ammonium removal in swimming pools, municipal water systems, industrial water discharge streams, fisheries, fish farms, and aquariums.

☐ <u>Sewage Treatment</u>. Zeolite is used in sewage treatment plants to remove nitrogen and as a carrier for microorganisms.

☐ <u>Nuclear Waste and Other Environmental Cleanup</u>. Zeolite has shown a strong ability to selectively remove strontium, cesium, radium, uranium, and various other radioactive isotopes from solution. Zeolite can also be used for the cleanup of soluble metals such as mercury, chromium, copper, lead, zinc, arsenic, molybdenum, nickel, cobalt, antimony, calcium, silver and uranium.

☐ <u>Odor Control</u>. A major cause of odor around cattle, hog, and poultry feed lots is the generation of the ammonium in urea and manure. The ability of zeolite to absorb ammonium prevents the formation of ammonia gas, which disperses the odor.

☐ <u>Gas Separation</u>. Zeolite has been used for some time to separate gases, to re-oxygenate downstream water from sewage plants, smelters, pulp and paper plants, and fishponds and tanks, and to remove carbon dioxide, sulfur dioxide and hydrogen sulfide from methane generators as organic waste, sanitary landfills, municipal sewage systems, animal waste treatment facilities, and is excellent in pressure swing apparatuses.

☐ <u>Animal Nutrition</u>. According to third-party research, feeding up to 2% zeolite increases growth rates, decreases conversion rates, and prevents scours.

☐ <u>Miscellaneous Uses</u>. Other uses include catalysts, petroleum refining, concrete, solar energy and heat exchange, desiccants, pellet binding, horse and kitty litter, floor cleaner, traction control, ammonia removal from mining waste, and carriers for insecticides, pesticides and herbicides.

**SELECTED FINANCIAL DATA.**

**Consolidated Statements of Operations Information:**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the Three Months**<br>**Ended June 30,** | **For the Three Months**<br>**Ended June 30,** | **For the Six Months**<br>**Ended June 30,** | **For the Six Months**<br>**Ended June 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Revenues | $10525123 | $3662977 | $17525128 | $6735044 |
| Costs of revenues | 7687578 | 2412754 | 12315853 | 4895336 |
| Gross profit | 2837545 | 1250223 | 5209275 | 1839708 |
| Total operating expenses | 2817538 | 1194215 | 4831276 | 2254154 |
| Income (loss) from operations | 20007 | 56008 | 377999 | (414446) |
| Total other income, net | 161548 | 146784 | 350080 | 294470 |
| Income tax expense | - | - | - | - |
| Net income (loss) | $181555 | $202792 | $728079 | ($119976) |

---

**Consolidated Balance Sheets Information:**

---

| | | |
|:---|:---|:---|
|  | **June 30,** <br>**2025** | **December 31,** <br>**2024** |
| Working capital | $9679441 | $16672180 |
| Total assets | 47498322 | 34642602 |
| Accumulated deficit | (40420944) | (41149023) |
| Total stockholders' equity | 37505943 | 28600673 |

---

---

| |
|:---|
| 28 |
| *[**Table of Contents**](#TOC)* |

---

**Operational and Financial Performance of Operations by Segment:**

***Antimony***

Financial and operational performance of antimony for the three months ended June 30, 2025 and 2024 was as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **For the three months**<br>**ended June 30,** | **For the three months**<br>**ended June 30,** | |  |  |
| <br>**Antimony** | **2025** | **2024** | <br>**$ Change** | **% Change** | **% Change** |
| Revenue (a) | $9636842 | $2663975 | $6972867 |  | 262% |
| Gross profit (a) | $2881083 | $1239598 | $1641485 |  | 132% |
| Pounds of antimony sold (a) | 340305 | 382769 | (42464) | (11) | (11)% |
| Average sales price per pound | $28.32 | $6.96 | $21.36 |  | 307% |
| Average cost per pound | $19.85 | $3.72 | $16.13 |  | 433% |
| Average gross profit per pound | $8.47 | $3.24 | $5.23 |  | 161% |

---

a. Revenue from sales of gold and silver totaled $nil and $4,616 for the three months ended June 30, 2025 and 2024, respectively, which are excluded from Revenue and Gross profit in the table above but included in the antimony segment. Pounds of antimony sold in the table above exclude sales related to gold and silver for both periods presented.

Financial and operational performance of antimony for the six months ended June 30, 2025 and 2024 was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the six months**<br>**ended June 30,** | **For the six months**<br>**ended June 30,** | | |
| <br>**Antimony** | **2025** | **2024** |<br>**$ Change** |<br>**% Change** |
| Revenue (b) | $15562690 | $5133037 | $10429653 | 203% |
| Gross profit (b) | $5304699 | $2147576 | $3157123 | 147% |
| Pounds of antimony sold (b) | 702952 | 884815 | (181863) | (21)% |
| Average sales price per pound | $22.14 | $5.80 | $16.34 | 282% |
| Average cost per pound | $14.59 | $3.37 | $11.22 | 333% |
| Average gross profit per pound | $7.55 | $2.43 | $5.12 | 211% |

---

b. Revenue from sales of gold and silver totaled negative $(20539) and $4,616 for the six months ended June 30, 2025 and 2024, respectively, which are excluded from Revenue and Gross profit in the table above but included in the antimony segment. Pounds of antimony sold in the table above exclude sales related to gold and silver for both periods presented.

For the three and six months ended June 30, 2025, antimony revenue increased $6,972,867, or 262%, and $10,429,653, or 203%, respectively, as compared to the corresponding periods in the prior year. This growth was primarily driven by heightened demand for antimony, which resulted in the average sales price per pound increasing for both the three and six-month periods. This positive impact from higher prices was partially offset by declines in sales volume of 11% and 21% during the three and six months ended June 30, 2025, respectively.

Gross profit increased $1,641,485, or 132%, and $3,157,123, or 147%, for the three and six months ended June 30, 2025, respectively, as compared to the three and six months ended June 30, 2024. These increases were primarily attributable to higher average sales prices per pound, driven by greater demand, coupled with favorable ore costs from earlier purchases made during the first half of 2025. This positive impact was partially offset by an increasing percentage of market prices charged by suppliers.

---

| |
|:---|
| 29 |
| *[**Table of Contents**](#TOC)* |

---

***Zeolite***

Financial and operational performance of zeolite for the three months ended June 30, 2025 and 2024 was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the three months**<br>**ended June 30,** | **For the three months**<br>**ended June 30,** | | |
| <br>**Zeolite** | **2025** | **2024** |<br>**$ Change** |<br>**% Change** |
| Revenue | $888281 | $994386 | $(106105) | (11)% |
| Gross profit | $122447 | $50669 | $71778 | 142% |
| Tons of zeolite sold | 3084 | 3735 | (651) | (17)% |
| Average sales price per ton | $288 | $266 | $22 | 8% |
| Average cost per ton | $248 | $253 | $(5) | (2)% |
| Average gross profit per ton | $40 | $14 | $26 | 186% |

---

Financial and operational performance of zeolite for the six months ended June 30, 2025 and 2024 was as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **For the six months**<br>**ended June 30,** | **For the six months**<br>**ended June 30,** | |  |  |
| <br>**Zeolite** | **2025** | **2024** | <br>**$ Change** | **% Change** | **% Change** |
| Revenue | $1982977 | $1597391 | $385586 |  | 24% |
| Gross profit (loss) | $301533 | $(242164) | $543697 |  | 225% |
| Tons of zeolite sold | 6886 | 6008 | 878 |  | 15% |
| Average sales price per ton | $288 | $266 | $22 |  | 8% |
| Average cost per ton | $244 | $306 | $(62) | (20) | (20)% |
| Average gross profit (loss) per ton | $44 | ($40) | $84 |  | 210% |

---

For the six months ended June 30, 2025, Zeolite revenue increased $385,586, or 24%, as compared to the corresponding prior year period. This increase was largely a result of higher sales volume, stemming from enhanced customer relationships, improved supply reliability, and broader customer reach. In contrast, Zeolite revenue in the second quarter of 2025 experienced a decline of $106,105, or 11%, when compared to the prior year's second quarter. This quarterly decrease was predominantly due to a 17% decrease in tons of Zeolite sold, partially offset by an 8% increase in the average sales price per ton.

Gross profit increased $543,697, or 225%, for the six months ended June 30, 2025, as compared to the corresponding period in 2024. This increase was largely due to both sales volume growth and higher average sales prices, coupled with a decrease in maintenance and related costs. In the first two quarters of 2024, our BRZ facility incurred substantial maintenance and related costs to repair older operating equipment due to historically poor maintenance practices. Despite these overall positive trends, Zeolite's gross profit saw more modest growth, increasing only $71,778, or 142%, in the second quarter of 2025 as compared to the prior year's second quarter. This was primarily the result of a decline in Zeolite sales volume during the second quarter of 2025.

**Capital Resources and Liquidity:**

---

| | | |
|:---|:---|:---|
| **Working Capital**  | **June 30, 2025** | **December 31, 2024** |
| Current assets | $17676473 | $20678569 |
| Current liabilities | (7997032) | (4006389) |
| Working capital | $9679441 | $16672180 |
|  | **For the Six Months**<br>**Ended June 30,** | **For the Six Months**<br>**Ended June 30,** |
| **Cash Flow Information** | **2025** | **2024** |
| Net cash (used in) provided by operating activities | ($2356986) | $630966 |
| Net cash used in investing activities | (17384832) | (100039) |
| Net cash provided by (used in) financing activities | 7279344 | (39071) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net (decrease) increase in cash | ($12462474) | $491856 |

---

---

| |
|:---|
| 30 |
| *[**Table of Contents**](#TOC)* |

---

Net cash used in operating activities was $2,356,986 for the six months ended June 30, 2025 as compared to $630,966 of net cash provided by operating activities for the six months ended June 30, 2024. This use of cash in 2025 primarily related to significantly increased antimony inventory on hand throughout the first two quarters of 2025, as shown in the inventory chart below. This use of cash was partly offset by an increased accounts payable balance during the first six months of 2025, which was largely due to the higher cost of supplier invoices related to antimony.

Inventory by segment as of the date indicated was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **December 31,**<br> **2023** | **June 30,** <br>**2024** | **December 31,** <br>**2024** | **June 30,** <br>**2025** |
| Antimony inventory | $881063 | $85426 | $744550 | $6427717 |
| Zeolite inventory | 505046 | 376928 | 501174 | 384810 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total inventories | $1386109 | $462354 | $1245724 | $6812527 |

---

Also, prepaid expenses and other current assets totaled $1,353,208 and $104,161 as of June 30, 2025 and December 31, 2024, respectively, which is an increase of $1,249,047. This increase was due in part to a payment made during the second quarter of 2025 for a shipment of inventory that had not been received by June 30, 2025. This resulted in an increase in "prepaid expenses and other current assets" of approximately $840,000 from December 31, 2024 to June 30, 2025. Also, prepaid insurance increased by approximately $342,000 from December 31, 2024 to June 30, 2025, due to insurance renewal payments made during the second quarter of 2025 to continue coverage for the next policy year.

In addition, accrued liabilities totaled $1,251,778 and $1,427,146 as of June 30, 2025 and December 31, 2024, respectively, and relate primarily to accrued compensation and accruals for goods or services received but not invoiced as of the reporting date. The $175,368 decrease reflected a reduction in accrued compensation that was primarily due to timing differences associated with payroll accruals.

Net cash used in investing activities increased to $17,384,832 for the six months ended June 30, 2025 as compared to $100,039 for the six months ended June 30, 2024. Investing activities in the first six months of 2025 were comprised of $9,991,259 for the purchase of U.S. Treasury Strips and capital expenditures totaling $7,394,073. These capital expenditures included $5,025,120 for the Fostung Properties, a mining property consisting of 50 single-cell mining claims located in the Sudbury District of Ontario, Canada. See *Note 8* of the *Notes to Condensed Consolidated Financial Statements* in this Quarterly Report for further information.

Net cash provided by financing activities was $7,279,344 for the six months ended June 30, 2025 as compared to $39,071 of net cash used in financing activities for the six months ended June 30, 2024. Financing activities in the first six months of 2025 included $5,064,483 of net proceeds received from the sale of common stock in an "at the market offering" and $2,225,411 of proceeds received from the exercise of pre-existing common stock warrants.

Our mission is to service our employees, customers, and vendors well and grow our business profitably both organically and through strategic acquisitions and partnerships to increase shareholder value. The Company is focused on generating cash flow to fund its mission. One method of generating cash is through the sale or issuance of common stock, warrants, debt, and other investment vehicles, which the Company has been successful at executing in the past. However, our ability to access capital or raise funds when needed is not assured and, if capital is not available when, and in the amounts and terms needed, or if capital is not available at all, the Company could be required to significantly curtail its operations, modify existing strategic plans, and/or dispose of certain operations or assets, which could materially harm our business, prospects, financial condition, and operating results.

---

| |
|:---|
| 31 |
| *[**Table of Contents**](#TOC)* |

---

The Company secured a $5,000,000 LOC facility in April 2025, which bears interest at one percent above the base commercial rate. The Company's U.S. Treasury Strips serve as collateral for this LOC. The Company could generate funds or working capital by drawing on its LOC as it had no outstanding borrowings on the LOC at June 30, 2025.

The Company could also receive funds from the U.S. Government for initiatives related to facility expansion and mining exploration and development. However, there is no assurance that U.S. Government funding will ultimately be accessible to the Company.

In addition, the Company continues to review each segment's operational and financial results for opportunities to improve cash flow and to make informed decisions that benefit the Company overall.

As of June 30, 2025, the Company had cash and cash equivalents of $5,708,660. We intend to fund our cash requirements with our cash and cash equivalents, cash generated from our operations, and capital raised from various investment vehicles and methods and believe cash from these sources are sufficient to cover our requirements for the next 12 months. We may use cash to acquire businesses. As noted per the "DESCRIPTION OF BUSINESS – History" section above, the Company is currently considering the acquisition of additional property in Alaska to be used for operating activities, including ore separation and storage, as well as an office for its staff. The nature of these investments and transactions, however, makes it difficult to predict the amount and timing of such cash requirements.

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

Not applicable.

**ITEM 4. CONTROLS AND PROCEDURES**

**Conclusions of Management Regarding Effectiveness of Disclosure Controls and Procedures**

At the end of the period covered by this Quarterly Report on Form 10-Q, an evaluation was carried out under the supervision and with the participation of the Company's management, including the Principal Executive Officer ("PEO") and Principal Financial Officer ("PFO"), of the effectiveness of the design and operations of the Company's disclosure controls and procedures (as defined in Rule 13a – 15(e) and Rule 15d – 15(e) under the Exchange Act). Based on that evaluation, the PEO and the PFO have concluded that our disclosure controls and procedures were not effective in ensuring that: (i) information required to be disclosed by the Company in reports that it files or submits to the SEC under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in applicable rules and forms, and (ii) material information required to be disclosed in our reports filed under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow for accurate and timely decisions regarding required disclosure.

Management of the Company believes that these material weaknesses are more so due to the small size of the Company's accounting staff. To continue to address this matter, in 2025, the Company has hired employees to lead Sarbanes-Oxley compliance, SEC and other reporting, accounts payable, finance and accounting in Mexico, and information technology. The Company is reviewing additional plans to strengthen its internal controls. These plans are ongoing and include: (i) reviewing accounting software packages for improved internal controls, (ii) determining whether controls can be implemented to mitigate segregation of duties issues, (iii) automating manual processes to improve the effectiveness and efficiency of internal controls, and (v) designing certain entity-level controls for a more effective control environment.

**Changes in Internal Control over Financial Reporting**

There have been no changes during the quarter ended June 30, 2025 in the Company's internal controls over financial reporting that have materially affected, or are reasonably likely to materially affect, internal controls over financial reporting.

---

| |
|:---|
| 32 |
| *[**Table of Contents**](#TOC)* |

---

**PART II - OTHER INFORMATION**

**ITEM 1. LEGAL PROCEEDINGS.**

United States Antimony Corporation is not a party to any material legal proceedings. No director, officer or affiliate of United States Antimony Corporation and no owner of record or beneficial owner of more than 5% of the Company's securities or any associate of any such director, officer or security holder is a party adverse to United States Antimony Corporation or has a material interest adverse to United States Antimony Corporation in reference to pending litigation.

**ITEM 1A. RISK FACTORS.**

There have been no material changes from the risk factors previously disclosed in the Company's Form 10-K/A for the year ended December 31, 2024, which was filed with the SEC on April 18, 2025, except as described below.

---

| |
|:---|
| ***Changes in United States trade policies, including the imposition of tariffs and retaliatory tariffs, may adversely impact our business, financial condition, and results of operations.*** Potential tariffs and trade restrictions may, among other things, cause the prices of ore and our product upon import into the US to increase, which could reduce demand for such products given the increased cost, and have a material adverse impact on our revenues, financial condition, and results of operations. In addition, to the extent changes in the political environment have a negative impact on us or on the markets in which we operate our business, our results of operations and financial condition could be materially and adversely impacted in the future. |
| ***Mining exploration, development, and production may not be economically viable***. On July 24, 2025, the Company published its technical report summary ("TRS") in accordance with the mining property disclosure rules specified in subpart 1300 of Regulation S-K ("SK 1300") on its zeolite mineral deposit located in Preston, Idaho. This TRS is an exhibit to the Form 8-K filed by the Company on July 25, 2025. However, the Company has not completed a TRS for any of its other properties. Until a TRS is completed for the Company's properties in accordance with SK 1300 or Canadian National Instrument 43-101 ("NI 43-101"), there can be no guarantee or assurance of the contents, quantity, or grade of mineral resources or reserves at the location. Any indication of the contents, quantity, or grade of minerals at these properties can be materially inaccurate. See "Cautionary Note Concerning Disclosure of Mineral Resources," above. In addition, we have not established proven or probable reserves, as defined under S-K 1300 or NI 43-101, through the completion of a feasibility study for these mining claims and leases. As a result, there is increased uncertainty and risk that may result in economic and technical failure which may materially adversely impact our future profitability, financial condition, and results of operations. |
| ***Processing and selling ore from new suppliers and internal sources may not be economically viable***. Ore sourced from new suppliers as well as ore sourced from our mine sites may not be able to be processed profitably, which could have a material adverse effect on our results of operations and financial condition. |
| ***More risk associated with non-domestic supply of antimony ore.*** The Company purchases ore from non-domestic suppliers, each purchase of which is typically for a material amount. There are many risks associated with purchasing ore from non-domestic suppliers. Due diligence is performed on each supplier, however, there can be no assurance that the information obtained is credible or accurate. In addition, there is no guarantee that the suppliers' product will be delivered to the Company, even after payment is made by the Company. Also, there can be no assurance that the product content, quantity, or grade will be as expected. As a result, there is increased uncertainty and risk related to purchasing product from non-domestic suppliers that could materially adversely impact our future profitability, financial condition, and results of operations. |

---

**ITEM 2. RECENT SALES OF UNREGISTERED SECURITIES.**

Not applicable.

**ITEM 3. DEFAULTS UPON SENIOR SECURITIES.**

None.

**ITEM 4. MINE SAFETY DISCOSURES.**

The information concerning mine safety violations or other regulatory matters required by Section 1503 (a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 104 of Regulation S-K is included in Exhibit 95 to this report.

**ITEM 5. OTHER INFORMATION.**

None.

---

| |
|:---|
| 33 |
| *[**Table of Contents**](#TOC)* |

---

**ITEM 6. EXHIBITS.**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| [3.1](http://www.sec.gov/Archives/edgar/data/101538/000165495424009959/uamy_ex31.htm) | [Third Restated Articles of Incorporation (incorporated by reference to Exhibit 3.1 to the Company's current Report on Form 8-K filed with the SEC on August 5, 2024).](http://www.sec.gov/Archives/edgar/data/101538/000165495424009959/uamy_ex31.htm) |
| [3.2](http://www.sec.gov/Archives/edgar/data/101538/000165495424006685/uamy_ex31.htm) | [First Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed with the SEC on May 20, 2024).](http://www.sec.gov/Archives/edgar/data/101538/000165495424006685/uamy_ex31.htm) |
| [31.1 \*](DocViewServlet?jobNumber=44343&docName=uamy_ex311.htm) | [Rule 15d-14(a) Certification by Principal Executive Officer.](DocViewServlet?jobNumber=44343&docName=uamy_ex311.htm) |
| [31.2 \*](DocViewServlet?jobNumber=44343&docName=uamy_ex312.htm) | [Rule 15d-14(a) Certification by Principal Financial Officer.](DocViewServlet?jobNumber=44343&docName=uamy_ex312.htm) |
| [32.1 \*](DocViewServlet?jobNumber=44343&docName=uamy_ex321.htm) | [Section 1350 Certification of Principal Executive Officer and Principal Financial Officer.](DocViewServlet?jobNumber=44343&docName=uamy_ex321.htm) |
| [95 \*](DocViewServlet?jobNumber=44343&docName=uamy_ex95.htm) | [Mine Safety Disclosure.](DocViewServlet?jobNumber=44343&docName=uamy_ex95.htm) |
| [96.1](http://www.sec.gov/Archives/edgar/data/101538/000165495425008485/uamy_ex961.htm) | [Technical Report Summary per SEC S-K 1300 - Bear River Zeolite **(incorporated by reference to Exhibit 96.1 to the Company's Current Report on Form 8-K filed with the SEC on July 25, 2025)**](http://www.sec.gov/Archives/edgar/data/101538/000165495425008485/uamy_ex961.htm) |
| 101.INS | Inline XBRL Instance Document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |

---

&nbsp;&nbsp;&nbsp;&nbsp;_____________________

\* Filed herewith.

---

| |
|:---|
| 34 |
| *[**Table of Contents**](#TOC)* |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **<u>UNITED STATES ANTIMONY CORPORATION</u>** | **<u>UNITED STATES ANTIMONY CORPORATION</u>** |
| Date: August 12, 2025 | By: | /s/ Gary C. Evans |
|  |  | Gary C. Evans |
|  |  | Chairman of the Board and CEO <br>(principal executive officer) |
| Date: August 12, 2025 | By: | /s/ Richard R. Isaak |
|  |  | Richard R. Isaak |
|  |  | SVP, Chief Financial Officer<br>(principal financial officer) |

---

## Exhibit 31.1

**EXHIBIT 31.1**

**Certification**

I, Gary C. Evans, certify that:

1. I have reviewed this quarterly report on Form 10-Q of United States Antimony Corporation for the quarter ended June 30, 2025;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 12, 2025

---

| |
|:---|
| /s/ Gary C. Evans |
| Gary C. Evans |
| Chairman of the Board and CEO |

---

## Exhibit 31.2

**EXHIBIT 31.2**

 **Certification**

I, Richard R. Isaak, certify that:

1. I have reviewed this quarterly report on Form 10-Q of United States Antimony Corporation for the quarter ended June 30, 2025;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 12, 2025

---

| |
|:---|
| /s/ Richard R. Isaak |
| Richard R. Isaak |
| SVP, Chief Financial Officer |

---

## Exhibit 32.1

**EXHIBIT 32.1**

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of United States Antimony Corporation (the "Company") on Form 10-Q for the quarter ended June 30, 2025, as filed with the Securities and Exchange Commission (the "Report"), Gary C. Evans, Chairman of the Board and Chief Executive Officer of the Company and Richard R. Isaak, SVP and Chief Financial Officer of the Company, each certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| /s/ Gary C. Evans  |
| Gary C. Evans |
| Chairman of the Board and CEO |
| Date: August 12, 2025 |
| /s/ Richard R. Isaak  |
| Richard R. Isaak |
| SVP, Chief Financial Officer |
| Date: August 12, 2025 |

---

## Ex-95

**EXHIBIT 95**

**MINE SAFETY DISCLOSURE**

Pursuant to Section 1503(a) of the recently enacted Dodd-Frank Wall Street Reform and Consumer Protection Act (the "Dodd-Frank Act"), issuers that are operators, or that have a subsidiary that is an operator, of a coal or other mine in the United States are required to disclose in their periodic reports filed with the SEC information regarding specified health and safety violations, orders and citations, issued under the Federal Mine Safety and Health Act of 1977 (the "Mine Act") by the Mine Safety and Health Administration (the "MSHA"), as well as related assessments and legal actions, and mining-related fatalities.

The following table provides information for the six months ended June 30, 2025:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| Mine | §104 Significant and Substantial Citations<br> (1) | §104(b) Orders (2) | §104(d) Citations and Orders<br> (3) | §110(b)(2) Violations<br> (4) | §107(a) Orders (5) | Proposed Assessments from MSHA (In dollars $) | Mining Related Fatalities | §104(e) Notice (yes/no)<br> (6) | Pending Legal <br> Action before <br> Federal Mine Safety <br> and Health <br> Review <br> Commission<br> (yes/no) |
| Bear River Zeolite | 1 | 0 | 0 | 0 | 0 | $4827 | 0 | No | No |

---

(1) The total number of violations received from MSHA under §104 of the Mine Act, which includes citations for health or safety standards that could significantly and substantially contribute to a serious injury if left unabated.

(2) The total number of orders issued by MSHA under §104(b) of the Mine Act, which represents a failure to abate a citation under §104(a) within the period of time prescribed by MSHA.

(3) The total number of citations and orders issued by MSHA under §104(d) of the Mine Act for unwarrantable failure to comply with mandatory health or safety standards.

(4) The total number of flagrant violations issued by MSHA under §110(b)(2) of the Mine Act.

(5) The total number of orders issued by MSHA under §107(a) of the Mine Act for situations in which MSHA determined an imminent danger existed.

(6) A written notice from the MSHA regarding a pattern of violations, or a potential to have such pattern under §104(e) of the Mine Act.